Suicidal Behavior and Severe Neuropsychiatric Disorders Following Glucocorticoid Therapy in Primary Care
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The incidence and the risk of suicidal behaviors and severe neuropsychiatric disorders in people treated with systemic glucocorticoids are poorly known. The authors assessed the incidence rates of depression, mania, delirium, panic disorder, and suicidal behaviors in patients treated with glucocorticoids in primary care settings and the risk factors for developing these outcomes. METHOD: Data were obtained for all adult patients registered between 1990 and 2008 at U.K. general practices contributing to The Health Improvement Network (THIN) primary care database. The incidence rates for the outcomes of interest were assessed in patients who received prescriptions for oral glucocorticoids and compared with those in patients who did not receive such prescriptions. The predictors of these outcomes in exposed patients were ascertained using Cox proportional hazards models. RESULTS: Overall, 786,868 courses of oral glucocorticoids were prescribed for 372,696 patients. The authors identified 109 incident cases of suicide or suicide attempt and 10,220 incident cases of severe neuropsychiatric disorders in these patients. The incidence of any of these outcomes was 22.2 per 100 person-years at risk for first-course treatments. Compared to people with the same underlying medical disease who were not treated with glucocorticoids, the hazard ratio for suicide or suicide attempt in exposed patients was 6.89 (95% CI=4.52–10.50); for depression, 1.83 (95% CI=1.72–1.94); for mania, 4.35 (95% CI=3.67–5.16); for delirium, confusion, or disorientation, 5.14 (95% CI=4.54–5.82); and for panic disorder, 1.45 (95% CI=1.15–1.85). Older men were at higher risk of delirium/confusion/disorientation and mania, while younger patients were at higher risk of suicide or suicide attempt. Patients with a previous history of neuropsychiatric disorders and those treated with higher dosages of glucocorticoids were at greater risk of neuropsychiatric outcomes. CONCLUSIONS: Glucocorticoids increase the risk of suicidal behavior and neuropsychiatric disorders. Educating patients and their families about these adverse events and increasing primary care physicians' awareness about their occurrence should facilitate early monitoring.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two meta-analyses 64,65 concluded that cortisol levels in MDD were elevated, with a moderate effect size.”
From Major depressive disorder (2016) · cites this paper as [65]
Citations
Cites
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847 · cited 1×
“Natural glucocorticoids such as cortisol affect behavior, mood, and other CNS-related processes (1).”
BackgroundDiagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
Herrett, E., Thomas, S. L., Schoonen, W. M., Smeeth, L., & Hall, A. J. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03537.x · Cited by 1,109
Psychiatric Adverse Effects of Corticosteroids
Warrington, T. P., & Bostwick, J. M. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.10.1361 · Cited by 611
Lewis, J. D., Schinnar, R., Bilker, W. B., Wang, X., & Strom, B. L. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1335 · Cited by 602
Population‐based assessment of adverse events associated with long‐term glucocorticoid use
Curtis, J. R., Westfall, A. O., Allison, J., Bijlsma, J. W., Freeman, A., George, V., Kovac, S. H., Spettell, C. M., & Saag, K. G. (2006) · Arthritis Care & Research · doi:10.1002/art.21984 · Cited by 595
Use of oral corticosteroids in the United Kingdom
van Staa, T. P. (2000) · QJM · doi:10.1093/qjmed/93.2.105 · Cited by 529
Steroid-induced psychiatric syndromes
Lewis, D. A., & Smith, R. E. (1983) · Journal of Affective Disorders · doi:10.1016/0165-0327(83)90022-8 · Cited by 528
The Read clinical classification.
Chisholm, J. (1990) · BMJ · doi:10.1136/bmj.300.6732.1092 · Cited by 504
Walsh, L. J., Wong, C. A., Pringle, M., & Tattersfield, A. E. (1996) · BMJ · doi:10.1136/bmj.313.7053.344 · Cited by 383
Research works printed but not linked: 2
- CSD Medical Research/EPIC, 2007, THIN Data From EPIC: A Guide for Researchers
- Reckart MD, 1990, Int J Psychosom, 37, 57
Cited by
Items 101–200 of 315
Psychiatric Aspects of Organ Transplantation in Critical Care
Sher, Y. I., & Zimbrean, P. C. (2017) · Critical Care Clinics · doi:10.1016/j.ccc.2017.03.009 · Cited by 15
Duis, J. B., Cox, O., Ji, Y., Seifuddin, F., Lee, R. S., & Wang, X. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00648 · Cited by 15
Risk of bipolar disorder in patients with COPD: a population-based cohort study
Tsai, P.-J., Liao, Y., Lee, C. T., Hsu, C., Hsieh, M., Tsai, C.-J., Hsieh, M.-H., & Chen, V. C. (2016) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2016.04.004 · Cited by 15
Glucocorticoid use and risk of suicide: a Danish population‐based case‐control study
Laugesen, K., Farkas, D. K., Vestergaard, M., Jørgensen, J. O. L., Petersen, I., & Sørensen, H. T. (2021) · World Psychiatry · doi:10.1002/wps.20831 · Cited by 15
Self-citationAvendaño-Lopez, S. S., Rodríguez-Marín, A. J., Lara-Castillo, M., Agresott-Carrillo, J., Lara-Cortés, L. E., Sánchez-Almanzar, J. F., Villamil-Cruz, S., Rojas-Rodríguez, L. C., Ariza-Salamanca, D. F., Gaviria-Carrillo, M., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12092131 · Cited by 14
“…or suicide attempt in patients with glucocorticoids was 6.89 (95% CI = 4.52–10.50); for depression, 1.83 (95% CI = 1.72–1.94); for mania, 4.35 (95% CI = 3.67–5.16); for delirium, confusion, or disorientation, 5.14 (95% CI = 4.54–5.82); and for panic disorder, 1.45 (95% CI = 1.15–1.85) [ 84].”
BackgroundResultInfluential[Psychiatric manifestations of autoimmune diseases--diagnostic and therapeutic problems].
Celińska‐Löwenhoff, M., & Musiał, J. (2012) · Psychiatria Polska · Cited by 14
Oral Corticosteroids for Skin Disease in the Older Population: Minimizing Potential Adverse Effects
Sparling, K., & Butler, D. C. (2024) · Drugs & Aging · doi:10.1007/s40266-024-01143-8 · Cited by 13
“Older adults taking oral corticosteroids are also at a higher risk for disorientation, delirium, cognitive changes, and memory decline [113, 114].”
Koning, A.-S. C. A. M., Habets, P. C., Bogaards, M., Kroon, J., van Santen, H. M., de Bont, J. M., & Meijer, O. C. (2022) · Endocrine Connections · doi:10.1530/ec-21-0425 · Cited by 13
“Cognitive and memory impairments and sleep disturbances are also well-known side effects [4, 5].”
BackgroundLagerberg, T., Gustafsson, T. T., Molero, Y., Forton, J. T., Sariaslan, A., Chang, Z., Larsson, H., Lichtenstein, P., & Fazel, S. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2025.128 · Cited by 12
“3 This and other studies have found that higher doses of glucocorticoids are associated with greater risk of psychiatric and behavioural outcomes, 3 – 5 and that age is a moderator of these risks.”
Primary Care of the Patient with Inflammatory Bowel Disease
Park, J. R., & Pfeil, S. A. (2015) · Medical Clinics of North America · doi:10.1016/j.mcna.2015.05.009 · Cited by 12
Drug-induced panic attacks: Analysis of cases registered in the French pharmacovigilance database
Abadie, D., Essilini, A., Fulda, V., Gouraud, A., Yelehe‐Okouma, M., Micallef, J., Montastruc, F., & Montastruc, J. L. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.02.008 · Cited by 12
Brown, E. S., Lu, H., Denniston, D., Uh, J., Thomas, B. P., Carmody, T. J., Auchus, R. J., Diaz-Arrastia, R., & Tamminga, C. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.01.038 · Cited by 11
“Keywords anticonvulsant; corticosteroid; fMRI; cognition; hippocampus Introduction Corticosteroids (a.k.a glucocorticoids) are commonly prescribed medications (Fardet et al., 2011) that are associated with a variety of neuropsychiatric side effects (Fardet et al., 2012; Wolkowitz et al., 2009).”
BackgroundGenomic and non-genomic effects of glucocorticoids in respiratory diseases
Lee, Z.-Y., & Tran, T. (2023) · Advances in pharmacology · doi:10.1016/bs.apha.2023.04.006 · Cited by 11
Cavalleri, L., Dassieni, I., Marcotto, G. S., Zoli, M., Pich, E. M., & Collo, G. (2024) · Neuroscience Applied · doi:10.1016/j.nsa.2024.104049 · Cited by 11
“Accordingly, in a large epidemiological study, exposure to synthetic glucocorticoids showed a 7-fold higher probability of suicide and 2-fold higher occurrence of MDD when compared to the normal population (Fardet et al., 2012).”
Yagi, Y., Takahashi, Y., Ogata, Y., Yamana, H., Kumakura, Y., Ichihashi, K., Kasai, K., & Kondō, S. (2021) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12204 · Cited by 11
Yin, Y., Tong, J., Huang, J., Wang, L., Tian, B., Chen, S., Tan, S., Wang, Z., Yu, T. Y., Li, Y., et al. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01554-5 · Cited by 10
“Abnormal glucocorticoids [50] or glucocorticoid receptors [51] are risk factors for suicides.”
BackgroundManipulating the Brain Corticosteroid Receptor Balance: Focus on Ligands and Modulators
de Kloet, E. R., Zacarías, N. V. O., & Meijer, O. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802175-0.00037-1 · Cited by 10
Parasher, A., & Bez, J. (2020) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20202296 · Cited by 10
“hippocampal level, a structure intimately involved in the limbic system, which is responsible for the processing of emotional information and memory.(15) Overproduction of cortisol through the activation of the hypothalamicpituitary-adrenal axis via negative feedback results in its high endogenous levels, which ultima…”
BackgroundGrover, S., Sahoo, S., Rijal, R., & Mehra, A. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100345 · Cited by 10
“…medical condition were for suicide and suicide attempt (adjusted HR: 6.89), followed by delirium, confusion or disorientation (adjusted HR: 5.14), mania (adjusted HR: 4.35), depression without psychotic symptoms (adjusted HR: 1.83), and panic disorder (adjusted HR: 1.45) (Fardet et al., 2012).”
InfluentialCorticoïdes et… infections, dopage, chirurgie et sexualité
Grossi, O., & Généreau, T. (2013) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.12.008 · Cited by 10
Koning, A.-S. C. A. M., Satoer, D., Vinkers, C. H., Najafabadi, A. H. Z., Biermasz, N. R., Tewarie, R. N., Moojen, W. A., van Rossum, E. F. C., Dirven, C. M. F., Pereira, A. M., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-054405 · Cited by 9
Zhang, B., Yang, M., Yan, Q., Xu, X., Niu, F., Dong, J., Zhuang, Y., Lu, S., Ge, Q., & Liu, B. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.713715 · Cited by 9
“Experimental studies have revealed that sufficient activation of MR is crucial for the normal functions of many structures in the brain, including the hippocampus and hypothalamus and that excessive or prolonged activation of GR caused by long-term synthetic GR agonist treatment or excessive endogenous GCs secretion (…”
BackgroundConsidering iatrogenic psychosis after malignant glioma resection
Shah, A. H., Gordon, C. E., Bregy, A., Shah, N. H., & Komotar, R. J. (2014) · BMJ Case Reports · doi:10.1136/bcr-2013-201318 · Cited by 9
“28 Notably depression has been associated with levetiracetam administration.”
Gürok, M. G., Yılmaz, S. A., Temizkan, A., Üstündağ, B., & Atmaca, M. (2018) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2018.1478191 · Cited by 9
“It has been reported that glucocorticoid levels, especially in patients who withdrew from steroid treatment, are closely related to depression, suicidal behavior, and panic disorder [27].”
BackgroundPost-transplant Psychosocial and Mental Health Care of the Liver Recipient
DiMartini, A. F., Golden, E., Matz, A., Dew, M. A., & Crone, C. C. (2018) · Springer eBooks · doi:10.1007/978-3-319-94914-7_15 · Cited by 9
Improving Depression Outcome by Patient-Centered Medical Management
Rush, A. J., & Thase, M. E. (2020) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.18207 · Cited by 9
Adverse Neurologic Effects of Medications Commonly Used in the Intensive Care Unit
Voils, S. A., Human, T., & Brophy, G. M. (2014) · Critical Care Clinics · doi:10.1016/j.ccc.2014.06.009 · Cited by 9
Prevention and monitoring of the side effects of chronic corticosteroid therapy
Nowak, K. M., & Papierska, L. (2014) · Postępy Nauk Medycznych · Cited by 9
Hormone circuit explains why most HPA drugs fail for mood disorders and predicts the few that work
Milo, T., Halber, S. N., Raz, M., Danan, D., Mayo, A., & Alon, U. S. (2025) · Molecular Systems Biology · doi:10.1038/s44320-024-00083-0 · Cited by 8
“Interestingly, Cushing ’ s tumors and corticosteroid drugs frequently cause mood episodes (Pivonello et al, 2015; Sonino and Fava, 2001; Sonino et al, 1998; Fardet et al, 2012; Judd et al, 2014).”
Steroid‐Induced Mental Disorders in Oncology Patients: A 10‐Year Retrospective Case Series Review
Seymour, N., Ismail, M. F., Doherty, K., Bowler, A., Bambury, R. M., Iqbal, S., & Cassidy, E. (2025) · Psycho-Oncology · doi:10.1002/pon.70137 · Cited by 8
King, J. D., Elliott, T., & Pitman, A. (2024) · Discover Mental Health · doi:10.1007/s44192-024-00061-w · Cited by 8
“However, an analysis of nationwide British general practice data reported a hazard ratio of 1.82 for likely SIM among those with a previously documented episode of mania, compared to matched unexposed persons [49].”
InfluentialNasib, L. G., Sommer, I. E., Rossum, I. W.-V., de Vries, J., Gangadin, S. S., Oomen, P. P., Judge, G., Blom, R. E., Luykx, J. J., van Beveren, N. J. M., et al. (2020) · Trials · doi:10.1186/s13063-020-04365-4 · Cited by 8
“3 for dosages up to 40mg prednisolone [38].”
BackgroundMoss, J. M., Kemp, D. W., & Brown, J. N. (2013) · Journal of Pharmacy Practice · doi:10.1177/0897190013504963 · Cited by 8
Lim, S. Y., & Bolster, M. B. (2019) · Springer eBooks · doi:10.1007/978-3-030-16928-2_28 · Cited by 8
Corticosteroid-Induced Psychiatric Symptoms #323
Campbell, R., Moreines, L. T., & Pruskowski, J. A. (2016) · Journal of Palliative Medicine · doi:10.1089/jpm.2016.0475 · Cited by 7
Gillespie, C. F., Szabo, S. T., & Nemeroff, C. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813866-3.00036-9 · Cited by 7
Conduites suicidaires et corticothérapie : à propos d’un cas
Carle, G., & Abgrall-Barbry, G. (2016) · L Encéphale · doi:10.1016/j.encep.2016.01.005 · Cited by 8
“événements est faible (19suicides et 90TS sur 372 696 patients suivis) [11].”
BackgroundThe Challenges of Clinical Psychopharmacological Management
Howland, R. H. (2012) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20120410-99 · Cited by 7
Couvaras, L., Trijau, S., Delamotte, G., Pradel, V., Pham, T., & Lafforgue, P. (2018) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2018.03.385 · Cited by 7
Laugesen, K., Petersen, I., Pedersen, L. H., Larsen, F. B., Jørgensen, J. O. L., & Sørensen, H. T. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030780 · Cited by 7
Self-citationPrimary CNS Lymphoma and Secondary Causes of Mania: A Case Report and Literature Review
Wang, C., & Fipps, D. C. (2021) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.21030084 · Cited by 7
Ghasemiyeh, P., Mortazavi, N., Karimzadeh, I., Vazin, A., Mahmoudi, L., Sarani, E. M., MohammadSadeghi, A., Shahisavandi, M., Kheradmand, A., & Mohammadi‐Samani, S. (2021) · PubMed Central · doi:10.22037/ijpr.2021.114717.15007 · Cited by 7
Corbett, B. M., Nordstrom, K., Vilke, G. M., & Wilson, M. P. (2016) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2016.05.055 · Cited by 7
“Another study found increasing risk of depression, delirium, confusion, and mania with advancing age, however, other neuropsychiatric manifestations such as panic disorders and suicidal ideation were less frequent with older age (13).”
Psychiatric sequelae of corticosteroid use in hematology in Australia: A qualitative study
Clifton, D. A., Ross, M., & O’Callaghan, C. C. (2018) · Nursing and Health Sciences · doi:10.1111/nhs.12395 · Cited by 6
Manía inducida por el tratamiento con corticoesteroides: revisión a partir de un caso clínico
García, M. D. S. D. L. N., Esquerdo, B. P., & Martínez, E. P. (2015) · Revista de la Asociación Española de Neuropsiquiatría · doi:10.4321/s0211-57352015000200007 · Cited by 6
George, C., Jyothi, K., & Shaji, K. (2016) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.196705 · Cited by 6
“[4] Chronic use of steroids may lead to the development of depressive symptoms.[5] However, our patient had developed manic symptoms–which was continuous in nature–even though he was getting only a low dose of prednisolone for quite a long time.”
BackgroundBrykalski, J., Papierska, L., & Załuska, M. (2015) · Psychiatria Polska · doi:10.12740/pp/28342 · Cited by 6
Ogyu, K., Mashima, Y., Nishi, A., Kusudo, K., Kato, H., Kurose, S., Uchida, H., Fujisawa, D., Mimura, M., & Takeuchi, H. (2023) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2023.111179 · Cited by 5
Perioperative Psychiatric Problems in Organ Transplantation
Zimbrean, P. C., & Proops, N. (2018) · Springer eBooks · doi:10.1007/978-3-319-99774-2_11 · Cited by 5
13- cis -Retinoic Acid Affects Brain Perfusion and Function: In Vivo Study
Al‐Saeedi, F. J., & Rajendran, P. (2023) · Molecular Imaging · doi:10.1155/2023/7855924 · Cited by 5
“…and mineralocorticoids are the driving forces and the trigger for many neuropsychiatric symptoms, e ff ects, and disorders, such as depression, quirk, mania, raving, hallucination, agitation, and even a sevenfold increased suicide or attempt average after the release of steroids [73, 74].”
BackgroundAsthme et comportements suicidaires chez les adolescents: revue systématique
Underner, M., Peiffer, G., Perriot, J., de Chazeron, I., & Jaafari, N. (2022) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2021.12.011 · Cited by 5
Clinical Pharmacology of Brain Tumor Chemotherapy
Avgeropoulos, N. G., & Newton, H. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812100-9.00002-4 · Cited by 5
Vasyl, R. R., Haran, B., Lahuta, T., Liberzon, I., & Dosenko, V. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149760 · Cited by 4
Psychiatric symptoms and syndromes in sarcoidosis: a systematic review and meta-analysis
Frans, A., Hoye, G. V., Meerbeeck, X. V., Morrens, M., & Eede, F. V. D. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1634175 · Cited by 4
“As it can even increase suicidal behavior patient education is warranted (109).”
Risk of suicide in cancer patients: nationwide cohort study
Yoo, J. E., Jung, W., Jung, J., Yoon, S. E., An, J. H., Han, K., & Shin, D. W. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2025.10384 · Cited by 4
“33 Patients with advanced or relapsed multiple myeloma have common complications including renal impairment, immunosuppression and pathologic fractures.”
Psychiatric Symptoms Associated with Corticosteroid Use: A Systematic Review and Meta-analysis
Kusudo, K., Mashima, Y., Yasuda, H., Iyo, T., & Takeuchi, H. (2026) · CNS Drugs · doi:10.1007/s40263-026-01298-5 · Cited by 4
“In contrast, although evidence directly linking long-term CS use to psychiatric symptoms is limited, longitudinal studies have suggested that depressive symptoms are the most frequently observed psychiatric manifestation in the context of prolonged CS exposure [7, 43, 55].”
InfluentialPrevention of Steroid-Induced Neuropsychiatric Complications With Neuroleptic Drugs: A Review
Akid, I., Nesbit, S. A., Nanavati, J., Bienvenu, O. J., & Smith, T. J. (2021) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/10499091211034771 · Cited by 4
“In Fardet’s retrospective analysis of primary care patients in the UK revealed that patients exposed to glucocorticoids had higher hazard ratio for suicide attempts, depression, mania, delirium and panic disorders.(15) Because palliative care doctors so commonly use corticosteroids, we reviewed the literature to deter…”
BackgroundRobbins-Welty, G. A., Chammas, D., Silverman, E., Lowry, M. F., Hale, E., Martinez, C., Nakatani, M. M., Shalev, D., Noufi, P. E., Riordan, P. A., et al. (2024) · Journal of Palliative Medicine · doi:10.1089/jpm.2024.0232 · Cited by 4
Complications Associated with Glucocorticoids Treatment in Critically Ill Patients
Confalonieri, P., Reccardini, N., Kette, S., & Salton, F. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2661-5208 · Cited by 4
“When exogenous GCs are administered — particularly at supraphysiologic doses — this feedback system becomes disrupted, leading to HPA axis suppression and rendering the adrenal glands unable to produce suf fi cient cortisol in the event of abrupt withdrawal.”
Glucocorticoid-Dependent Epigenetic Regulation of Fkbp5
Lee, R. S. (2016) · Epigenetics and human health · doi:10.1007/978-3-319-24493-8_4 · Cited by 5
Bülbüloğlu, S., Harmancı, P., & Aslan, F. E. (2023) · iLiver · doi:10.1016/j.iliver.2023.01.001 · Cited by 4
“Glucocorticoids affect the limbic system at the hippocampus level, and this can emerge along with symptoms such as cognitive dysfunctions, behavioral disorders, and depression including the increase in the risk of suicide [27,37].”
Bazo‐Alvarez, J. C., Avgerinou, C., Nimmons, D., Hayes, J., Osborn, D., Cooper, C., Walters, K. R., & Petersen, I. (2024) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.14256 · Cited by 5
Self-citationTseilikman, O. B., Kozochkin, D. A., Manukhina, E. B., Downey, H. F., Misharina, M. E., Komelkova, M. V., Nikitina, A. A., Golodnii, S. V., Додохова, М. А., & Цейликман, В. Э. (2016) · Stress · doi:10.1080/10253890.2016.1183118 · Cited by 4
“However, widespread use of GC therapy for PTSD is limited by its side effects (Fardet et al., 2012; Judd et al., 2014).”
BackgroundEmergence Delirium: Can Corticosteroids Contribute to It?
Esmel-Vilomara, R., Cruz, A., Inoriza, C., Andreu, E., & Munar, F. (2020) · Journal of Pediatric Intensive Care · doi:10.1055/s-0040-1709655 · Cited by 4
Two cases of steroid dementia showing partial recovery during 2‐year follow‐up
Ikeda, N., Yamada, S., Yamamoto, M., Tanaka, K., Fujii, T., Tsuji, T., Kimoto, S., & Takahashi, S. (2022) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.49 · Cited by 4
A Case of Corticosteroid-Responsive Depression
Vidal, E., Stewart, J. T., & Catalano, G. (2013) · Psychosomatics · doi:10.1016/j.psym.2013.01.004 · Cited by 4
Roberts, W. C., Won, V. S., Vasudevan, A., & Guileyardo, J. M. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.08.090 · Cited by 4
Les troubles bipolaires en oncologie : caractéristiques et prise en charge
Reich, M., & Kotecki, N. (2017) · Bulletin du Cancer · doi:10.1016/j.bulcan.2017.01.013 · Cited by 4
Singh, P., Gajjar, S. R., Upadhayay, P., Joshi, N. K., & Datusalia, A. K. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178434 · Cited by 3
Urgent Care Stewardship for Glucocorticoid Overuse in Acute Respiratory Infections
Patel, D. D., Dubois, T., Weston, V., Hasson, A., Keirnan, H., Malik, K., Miller, I., Blackketter, O., Liberius, K., Majer, J., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.9261 · Cited by 3
Koning, A.-S. C. A. M., Ottevanger, R., Vermeer, M. H., Meijer, O. C., & Giltay, E. J. (2024) · JAAD International · doi:10.1016/j.jdin.2024.07.015 · Cited by 3
“1,2 Although these more severe effects are recognized, the subtler implications of glucocorticoid therapy, which might be more common, have not been as extensively studied.”
BackgroundMEDICAMENTOS POTENCIALMENTE INAPROPRIADOS PARA PESSOAS IDOSAS NO SISTEMA ÚNICO DE SAÚDE (SUS)
Mascarenhas, I. D. J., Pereira, L. C., & de Andrade, K. V. F. (2025) · Infarma - Ciências Farmacêuticas · doi:10.14450/2318-9312.v36.e1.a2024.pp29-40 · Cited by 3
Steriod‐associated psychiatric burden in cancer patients
Günther, M. P., Riemann, P. M., von Känel, R., Euler, S., & Schulze, J. B. (2023) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13853 · Cited by 3
“A larger more recent study on patients in primary care in the United Kingdom supported these findings.(5) It reported a hazard ratio for suicide or suicide attempt in (particularly younger) patients treated with steroids of 6.”
ResultLeung, J., Deeble, N., Yang, V., Liew, D. F. L., Buchanan, R. R. C., & Owen, C. (2025) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000002219 · Cited by 3
Side Effects of Systemic Steroids and Management
Bayazit, S., Engіn, B., Kutlubay, Z., Aşkın, Ö., & Serdaroğlu, S. (2020) · Dermatoz · doi:10.4274/dermatoz.galenos.2019.76486 · Cited by 3
Stress, Vulnerability, and Suicide: The Stress–Diathesis Model
van Heeringen, K. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316563205.003 · Cited by 3
Kaufman, K. R. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139028899.006 · Cited by 3
Assessing Psychiatric Adverse Effects during Clinical Drug Development
Rudorfer, M. V., & Hillefors, M. (2012) · Pharmaceutical Medicine · doi:10.1007/bf03262382 · Cited by 3
Mindfulness for the Treatment of Stress Disorders
Pallesen, K. J., Dahlgaard, J., & Fjorback, L. O. (2015) · Springer eBooks · doi:10.1007/978-3-319-22255-4_8 · Cited by 3
Behavioral Medical Epigenetics
Cox, O., & Lee, R. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803239-8.00008-9 · Cited by 4
Khanam, A., Dar, S. A., & Wani, Z. A. (2021) · Journal of Medical Sciences · doi:10.4103/jmedsci.jmedsci_191_20 · Cited by 3
Perez, J. M., Murdock, S., Singh, S. S., & Zheng, W. (2021) · Heart and Mind · doi:10.4103/hm.hm_17_21 · Cited by 3
CLINICAL AND EPIDEMIOLOGICAL STUDIES IN MYELOPROLIFERATIVE NEOPLASMS
Hultcrantz, M. L. (2013) · Figshare · Cited by 3
King, T., Acret, L., Rutherford, C., Tait, M.-A., Jagger, J., Sipavicius, J., McCaughan, G. J. B., Joshua, D., & White, K. (2025) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2025.151943 · Cited by 2
Glucocorticoid Receptor–Regulated Gene Networks and Mental Health
Meaney, M. J., & Binder, E. B. (2026) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-102124-031826 · Cited by 2
Etayo-Urtasun, P., de Asteasu, M. L. S., & Izquierdo, M. (2026) · Sports Medicine · doi:10.1007/s40279-026-02469-6 · Cited by 2
“Depression presents an equally significant barrier, with glucocorticoid treatment conferring a twofold increased risk of depressive episodes (prevalence of 11.1% in glucocorticoid users compared to 4.1% in non-users) [30, 31].”
InfluentialMorfín, J. A., & Nizamic, T. J. (2024) · Springer eBooks · doi:10.1007/978-3-030-74720-6_56 · Cited by 3
Steroid-induced psychosis: a spectrum of neuropsychiatric glucocorticoid side effects
Santana, L., Medinas, R. L., Neves, A., & Gago, J. (2024) · BMJ Case Reports · doi:10.1136/bcr-2023-259134 · Cited by 2
Drug-induced dementia: a pharmacovigilance analysis of the FAERS database
Wang, Y., Kong, J.-H., Yang, Y., Zheng, Y., & Li, J. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2443106 · Cited by 2
“Some literature suggests glucocorticoid agonists are associated with increased risk of cognitive and psychiatric disorders [55].”
Unerwartete Folgen einer HNO-Standardtherapie
Huseynov, J., & Mozet, C. (2018) · Laryngo-Rhino-Otologie · doi:10.1055/s-0044-100257 · Cited by 2
Ducasse, D., Girod, C., & Courtet, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-26282-6_10 · Cited by 2
MANIA INDUCED BY STEROID-ADULTERATED HERBAL MEDICINE: A CASE REPORT
Gan, L. L. Y., Woon, L. S., Zawawi, M. U., & Midin, M. (2018) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2018.v11i5.25640 · Cited by 2
Association of Megestrol Use With the Development of New Psychiatric Diagnoses
Ramamurthy, S., Enkevort, E. A. V., Xie, D., Palka, J. M., & Brown, E. S. (2020) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.01.003 · Cited by 2
Ghaly, R. F., Plesca, A., Candido, K. D., & Knežević, N. N. (2020) · Surgical Neurology International · doi:10.25259/sni_58_2020 · Cited by 2
“e absence of suicidal ideation, however, does not exclude the risk of suicide, and researchers believe that depression, hopelessness, most mental disorders, and even impulsivity predict ideation, but these factors struggle to distinguish those who have attempted suicide from those who have only considered suicide [Ta…”
BackgroundPrescription patterns of psychotropics in patients receiving synthetic glucocorticoids
Yatomi, T., Uchida, T., Takeuchi, H., Kuramochi, S., Yoshimura, K., Mimura, M., & Uchida, H. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13217 · Cited by 2
“For example, the risk of suicide and suicide attempts was reportedly seven times higher in patients receiving glucocorticoid therapy than that in non-users (7).”
BackgroundIntroduction to epigenetics in psychiatry
Lee, R. S., & Avramopoulos, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823577-5.00009-x · Cited by 2
Mania after long‐term treatment with daily 10 mg prednisolone
Fujii, R., Konishi, Y., Furusawa, R., Okamoto, N., & Yoshimura, R. (2022) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.66 · Cited by 2
“10 This patient's past presentation with elevated mood may have been a risk factor for her mania.”
BackgroundManaging Cluster Headache in Patients with Medical, Psychiatric, and Surgical Comorbidities
Burish, M. J., Guirguis, A. B., & Schindler, E. A. D. (2024) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-024-01362-x · Cited by 2
Lescano, P., & Karen, P. (2018) · Repositorio Institucional Universidad de Huanuco · Cited by 2
Investigating the Behavioural and Electrophysiological Consequences of Early Life Stress
Wilkinson, M. P. (2021) · Bristol Research (University of Bristol) · Cited by 2
Metadata
- Authors
- Fardet, L., Petersen, I., & Nazareth, I.
- Affiliations
- The Royal Free Hospital (GB)
- Venue
- American Journal of Psychiatry
- Published
- 2012-05
- Volume
- 169
- Issue
- 5
- Pages
- 491-497
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W1972710070
- Semantic Scholar
- 685aae4b79751dcc2039c2233ce3afa9e737b047
- Cited by
- 287
- References
- 35
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 18 · 2023: 20 · 2022: 20 · 2021: 30 · 2020: 25 · 2019: 9 · 2018: 40 · 2017: 18 · 2016: 23 · 2015: 15 · 2014: 21 · 2013: 13 · 2012: 7
- FWCI
- 20.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- glucocorticoids, suicidal behavior, suicide attempts, neuropsychiatric disorders, depression, mania, delirium, panic disorder, adverse drug reactions, primary care, incidence, risk factors, glucocorticoid dose, older men, young men, patient education, adverse event monitoring, primary care prescribing, pharmacovigilance, antipsychotic prescribing
- MeSH terms
- Mental Disorders, Bipolar Disorder, Confusion, Delirium, Depression, Female, Glucocorticoids, United Kingdom, Humans, Male, Middle Aged, Primary Health Care, Risk Factors, Suicide, Suicide, Attempted, Proportional Hazards Models, Panic Disorder
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.